SS
IRWD icon

SBI Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History

SBI Securities’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.52K Buy
1,311
+25
+2% +$96 ﹤0.01% 2129
2026
Q1 		$4.51K Buy
1,286
+1,220
+1,848% +$5K ﹤0.01% 2069
2025
Q4 		$222 Sell
66
-2
-3% -$5 ﹤0.01% 3175
2025
Q3 		$89 Sell
68
-2
-3% -$2 ﹤0.01% 3548
2025
Q2 		$50 Buy
70
+7
+11% +$5 ﹤0.01% 3720
2025
Q1 		$93 Sell
63
-4
-6% -$10 ﹤0.01% 3465
2024
Q4 		$297 Buy
+67
New +$272 ﹤0.01% 3094

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SBI Securities's IRWD Position: Q2 2026 in Review

SBI Securities increased its Ironwood Pharmaceuticals (IRWD) stake by 1.9% in Q2 2026, buying an estimated $96 and bringing the position to 1,311 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

SBI Securities first reported a position in IRWD in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • SBI Securities held 1,311 shares of Ironwood Pharmaceuticals worth $5.52K as of Q2 2026.
  • SBI Securities bought 25 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $96.
  • Ironwood Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2129 holding.
  • SBI Securities first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.